Important note
This AI stock analysis for Teladoc Health is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Teladoc Health - AI Stock Analysis
Analysis generated June 13, 2025
Teladoc Health, Inc. is a provider of telemedicine services, including virtual healthcare and wellness services on a global scale. The company connects millions of people to the highest quality healthcare through its robust telehealth platform. Leveraging the power of technology and an extensive network of healthcare professionals, Teladoc Health aims to create better healthcare experiences for both patients and practitioners.
Fundamental Analysis
Revenue for the last quarter stood at $629 million. This figure represents a decrease of 1.74% compared to the previous quarter and a 2.59% decrease compared to the same quarter last year, signaling a need for concern regarding the company's growth momentum.
Net income for the last quarter was $93 million, showing a significant decrease of 92.14% from the prior quarter and a 13.58% decrease compared to the same period last year. This dramatic reduction in net income is troubling and may indicate underlying financial issues.
The company’s EBITDA for the last quarter was $121 million. Shockingly, this figure represents a sharp decline of 339.56% from the prior quarter and a 547.45% decrease from the year-ago period, raising red flags about the company's operational efficiency.
It's worth noting that in recent months, several company insiders have sold their stocks, which is often viewed as a bearish signal and raises concerns about the confidence of those closest to the company's operations.
Technical Analysis
Today’s stock price is $7.03. This represents a decrease of 7.74% compared to a month ago and a 29.70% decrease compared to a year ago. The trend is evidently bearish.
The current Simple Moving Average (SMA10) is $7.23, which is lower than the previous SMA10, suggesting a potential downward trend in price movement. The Relative Strength Index (RSI) is 45.9, indicating a neutral condition, neither overbought nor oversold, but leaning toward the lower end of the spectrum.
Alternative Data Analysis
In terms of job postings and employee sentiment, Teladoc Health currently has 77 open positions. This is down by 21% over the last couple of months, signifying a possible effort to cut costs or improve margins. Only 33% of employees have a positive business outlook, which is quite concerning. This sentiment is down by 13% in the last couple of months.
Regarding customer acquisition, the company has an estimated 670,000 visitors to their webpage, which is down by 26% in recent months. However, the number of daily mobile app downloads is up by 28% to 1,900, indicating a growing interest in their mobile solutions.
As for customer engagement, Teladoc Health has 14,000 followers on Instagram, with a growth of 4% in recent months. On Twitter, the company has 18,000 followers, but this number is down by 1%, portraying a mixed picture of public interest.
It's important to consider AltIndex's AI score, which aims to predict stock prices based on a combination of fundamental, technical, and alternative data analyses. Teladoc Health currently has an AI score of 47, which is classified as a hold signal.
Conclusion and Recommendation
Teladoc Health presents a mixed bag of indicators. On the one hand, the company is witnessing concerning decreases in revenue, net income, and EBITDA. The bearish trend in stock price and the sale of shares by company insiders further complicate the outlook. However, on the alternative data front, increases in mobile app downloads and Instagram followers offer a glimmer of hope.
Based on the fundamental, technical, and alternative data analyses, it may be advisable to hold the stock. While there are areas showing promise, several concerning trends suggest a cautious approach in the short to medium term. Investors should continue to closely monitor these metrics for any signs of improvement or further decline.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
